Zobrazeno 1 - 10
of 1 125
pro vyhledávání: '"Hee-Je Kim"'
Publikováno v:
Journal of Materials Research and Technology, Vol 32, Iss , Pp 621-633 (2024)
Hastelloy C276, known for its high temperature strength and corrosion resistance, is essential in the manufacture of medical devices and aerospace components. This study developed a micro-controlled GTA welding technology capable of precisely welding
Externí odkaz:
https://doaj.org/article/b8b6c8daace945e9b8f1707ffc2c2a41
Publikováno v:
Safety and Health at Work, Vol 14, Iss 4, Pp 451-456 (2023)
Background: We conducted a case-control study to identify high-risk occupations and exposure to occupational hazards for acute myeloid leukemia (AML). Methods: When patients with AML admitted to the Department of Hematology in the study hospital for
Externí odkaz:
https://doaj.org/article/c9b28fcf2bea4e5a8f312eaac6194dcc
Autor:
Gi-June Min, Young-Woo Jeon, Tong Yoon Kim, Daehun Kwag, Byung-Su Kim, Joonyeop Lee, Jong Hyuk Lee, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong Wook Lee, Seok-Goo Cho
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract To clarify the role of allogeneic hematopoietic stem-cell transplantation (allo-HSCT) in the chimeric antigen receptor T-cell therapy era, we analyzed the clinical characteristics and outcomes of 52 patients treated with allo-HSCT with relap
Externí odkaz:
https://doaj.org/article/568101353413408dae23b839c241202a
Autor:
Gi-June Min, Byung-Sik Cho, Daehun Kwag, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIntensive chemotherapy (IC) can affect all geriatric assessment (GA) domains in older adults with acute myeloid leukemia (AML), but data on the effects of these changes on transplant outcomes are lacking.MethodsTherefore, we prospectively
Externí odkaz:
https://doaj.org/article/65b2e181f5394060b08b561448fa911d
Autor:
Jinho Jang, Hongtae Kim, Sung-Soo Park, Miok Kim, Yong Ki Min, Hyoung-oh Jeong, Seunghoon Kim, Taejoo Hwang, David Whee-Young Choi, Hee-Je Kim, Sukgil Song, Dong Oh Kim, Semin Lee, Chang Hoon Lee, Jong Wook Lee
Publikováno v:
HemaSphere, Vol 7, Iss 11, p e977 (2023)
Aplastic anemia (AA) is a lethal hematological disorder; however, its pathogenesis is not fully understood. Although immunosuppressive therapy (IST) is a major treatment option for AA, one-third of patients do not respond to IST and its resistance me
Externí odkaz:
https://doaj.org/article/c8c7345de35344688ee87ab7ab285e4a
Autor:
Silvia Park, Tong Yoon Kim, Byung-Sik Cho, Daehun Kwag, Jong-Mi Lee, MyungShin Kim, Yonggoo Kim, Jamin Koo, Anjali Raman, Tae Kon Kim, Hee-Je Kim
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
This study aimed to validate the new European Leukemia Net (ELN) 2022 criteria for genetic risk stratification in older adults with acute myeloid leukemia (AML) and to determine the most likely set of clusters of similar cytogenetic and mutation prop
Externí odkaz:
https://doaj.org/article/628422829bb5489398c21a66ef1a1146
Autor:
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-8 (2022)
Abstract Venetoclax (VEN) combined with azacitidine (AZA) or decitabine (DEC) has been approved for older adults with acute myeloid leukemia (AML) unfit for intensive chemotherapy based on the pivotal VIALE-A trial. However, this trial only compared
Externí odkaz:
https://doaj.org/article/474caaa9b9e54019a124a502c0ba8ce5
Autor:
Richard Schlenk, Pau Montesinos, Antonio Romero-Aguilar, Radovan Vrhovac, Elżbieta Patkowska, Hee-Je Kim, Pavel Zak, Po-Nan Wang, James Hanyok, LI Liu, Yasser Mostafa Kamel, Aziz Benzohra, Arnaud Lesegretain, Jorge Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Alexander E. Perl, Mark J. Levis, Harry P. Erba
Publikováno v:
HemaSphere, Vol 7, p e61150fb (2023)
Externí odkaz:
https://doaj.org/article/161ac30cf9634f0ab1e0c386b591f284
Autor:
Mark J Levis, Harry P. Erba, Pau Montesinos, Radovan Vrhovac, Elżbieta Patkowska, Hee-Je Kim, Pavel Zak, Po-Nan Wang, Jaime E. Connolly Rohrbach, Ken C.N. Chang, James Hanyok, LI Liu, Yasser Mostafa Kamel, Arnaud Lesegretain, Jorge Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Alexander E. Perl
Publikováno v:
HemaSphere, Vol 7, p e446548f (2023)
Externí odkaz:
https://doaj.org/article/def63e6658704a3a951c965be0108d02
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Treating patients with refractory acute myeloid leukemia (AML) remains challenging. Currently there is no effective treatment for refractory AML. Increasing evidence has demonstrated that refractory/relapsed AML is associated with leukemic blasts whi
Externí odkaz:
https://doaj.org/article/16133de605be4219a840abe5f4e965a1